76 related articles for article (PubMed ID: 23307598)
1. Cytological characterization of murine bone marrow and spleen hematopoietic compartments for improved assessment of toxicity in preclinical gene marking models.
Yang M; Büsche G; Ganser A; Li Z
Ann Hematol; 2013 May; 92(5):595-604. PubMed ID: 23307598
[TBL] [Abstract][Full Text] [Related]
2. Morphology and quantitative composition of hematopoietic cells in murine bone marrow and spleen of healthy subjects.
Yang M; Büsche G; Ganser A; Li Z
Ann Hematol; 2013 May; 92(5):587-94. PubMed ID: 23307597
[TBL] [Abstract][Full Text] [Related]
3. The hematopoietic stromal microenvironment promotes retrovirus-mediated gene transfer into hematopoietic stem cells.
Chertkov JL; Jiang S; Lutton JD; Harrison J; Levere RD; Tiefenthaler M; Abraham NG
Stem Cells; 1993 May; 11(3):218-27. PubMed ID: 8318909
[TBL] [Abstract][Full Text] [Related]
4. Engraftment of SCID mice by human bone marrow hematopoietic cells cultured in vitro: an in vivo model for human gene transfer.
Spence SE; Keller JR; Ruscetti FW; Czarra KT; Gooya JM; Funakoshi S; Longo DL; Murphy WJ
Leukemia; 1995 Oct; 9 Suppl 1():S43-7. PubMed ID: 7475312
[TBL] [Abstract][Full Text] [Related]
5. CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells.
van Pel M; Hagoort H; Hamann J; Fibbe WE
Haematologica; 2008 Aug; 93(8):1137-44. PubMed ID: 18603564
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
[TBL] [Abstract][Full Text] [Related]
7. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
[TBL] [Abstract][Full Text] [Related]
8. MDS-like experimental myelodysplasia: multilineage abnormal hematopoiesis in transgenic mice harboring the SV40 large T antigen under an immunoglobulin enhancer.
Furuta Y; Aizawa S; Suda Y; Ikawa Y; Nishikawa S; Hayashi S; Hirabayashi Y; Inoue T
Exp Hematol; 1993 Jun; 21(6):806-15. PubMed ID: 8500578
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of repeated intravenous injection of gene therapeutics for X-CGD in mice.
Lee YM; Choi WH; Kim YB; Ha CS; Song CW; Lee M; Joo CW; Hong Y; Ho SH; Kim S; Kim JM; Koh WS
Hum Exp Toxicol; 2008 May; 27(5):401-7. PubMed ID: 18715886
[TBL] [Abstract][Full Text] [Related]
10. Homing of fluorescently labeled murine hematopoietic stem cells.
Hendrikx PJ; Martens CM; Hagenbeek A; Keij JF; Visser JW
Exp Hematol; 1996 Feb; 24(2):129-40. PubMed ID: 8641334
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow and peripheral white blood cells number is affected by sleep deprivation in a murine experimental model.
Guariniello LD; Vicari P; Lee KS; de Oliveira AC; Tufik S
J Cell Physiol; 2012 Jan; 227(1):361-6. PubMed ID: 21437906
[TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer into hematopoietic stem cells.
Nienhuis AW
Blood Cells; 1994; 20(1):141-7; discussion 147-8. PubMed ID: 7994057
[TBL] [Abstract][Full Text] [Related]
14. Transfer of marker genes into hemopoietic progenitor cells.
Brenner MK; Heslop HE; Rill D; Li C; Smith C; Krance R; Rooney C
Cytokines Mol Ther; 1996 Sep; 2(3):193-200. PubMed ID: 9384704
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of TGF-beta activity during retroviral transduction improves murine hematopoietic progenitor and repopulating cell gene transfer efficiency.
Yu J; Soma T; Hanazono Y; Dunbar CE
Gene Ther; 1998 Sep; 5(9):1265-71. PubMed ID: 9930329
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived human hematopoietic stem cells engraft NOD/SCID mice and traffic appropriately to an inflammatory stimulus in the joint.
Chang NH; Inman RD; Dick JE; Wither JE
J Rheumatol; 2010 Mar; 37(3):496-502. PubMed ID: 20110518
[TBL] [Abstract][Full Text] [Related]
17. Shp-2 heterozygous hematopoietic stem cells have deficient repopulating ability due to diminished self-renewal.
Chan RJ; Li Y; Hass MN; Walter A; Voorhorst CS; Shelley WC; Yang Z; Orschell CM; Yoder MC
Exp Hematol; 2006 Sep; 34(9):1230-9. PubMed ID: 16939816
[TBL] [Abstract][Full Text] [Related]
18. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
[TBL] [Abstract][Full Text] [Related]
19. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
Chen BP; Fraser C; Reading C; Murray L; Uchida N; Galy A; Sasaki D; Tricot G; Jagannath S; Barlogie B
Leukemia; 1995 Oct; 9 Suppl 1():S17-25. PubMed ID: 7475307
[TBL] [Abstract][Full Text] [Related]
20. Retrovirus-mediated expression of the base excision repair proteins, formamidopyrimidine DNA glycosylase or human oxoguanine DNA glycosylase, protects hematopoietic cells from N,N',N"-triethylenethiophosphoramide (thioTEPA)-induced toxicity in vitro and in vivo.
Kobune M; Xu Y; Baum C; Kelley MR; Williams DA
Cancer Res; 2001 Jul; 61(13):5116-25. PubMed ID: 11431349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
